These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 189293
1. The role of peptides in the central nervous system function. Wiśniewski K. Pol J Pharmacol Pharm; 1976; 28(6):647-54. PubMed ID: 189293 [Abstract] [Full Text] [Related]
2. Influence of albumin degradation products (ADP) on the central action of catecholamines. Tarasiewicz S, Buczko W, Wiśniewski K. Pol J Pharmacol Pharm; 1976; 28(6):691-6. PubMed ID: 1034926 [Abstract] [Full Text] [Related]
3. [Vasoactive substance and the lung]. Kitamura S. Kokyu To Junkan; 1973 Aug; 21(8):688-700. PubMed ID: 4354545 [No Abstract] [Full Text] [Related]
4. The effect of products of fibrinogen digestion by plasmin (P-FDP) on the central nervous system. Wiśniewski K, Buczko W, Moniuszko-Jakoniuk J. Acta Neurobiol Exp (Wars); 1975 Aug; 35(3):275-83. PubMed ID: 126007 [Abstract] [Full Text] [Related]
5. Influence of globulin degradation products (GDP) on some centrally acting drugs. Tarasiewicz S, Maćkowiak J, Moniuszko-Jakoniuk J, Michalak S. Acta Med Pol; 1977 Aug; 18(2):113-21. PubMed ID: 883513 [No Abstract] [Full Text] [Related]
6. Cyclic nucleotides and central cardiovascular control in the cat [proceedings]. Clipsham PJ, Hamilton TC, Hunt AE, Poyser RH. Br J Pharmacol; 1978 Nov; 64(3):395P. PubMed ID: 214195 [No Abstract] [Full Text] [Related]
7. Influence of fibrinogen degradation products on the action of amphetamine in the central nervous system. Zwoliński J, Buczko W. Pol J Pharmacol Pharm; 1977 Nov; 29(3):313-9. PubMed ID: 560684 [Abstract] [Full Text] [Related]
8. Anti-inflammatory effects of kinins via microglia in the central nervous system. Noda M, Kettenmann H, Wada K. Biol Chem; 2006 Feb; 387(2):167-71. PubMed ID: 16497148 [Abstract] [Full Text] [Related]
9. Interaction of fibrinopeptides A and B with dopaminergic receptors in central nervous system. Wawrzyniuk I, Buczko W, Wiśniewski K. Pol J Pharmacol Pharm; 1979 Feb; 31(4):365-72. PubMed ID: 574959 [Abstract] [Full Text] [Related]
10. [On the biological properties of some fibrinogen degradation products (FDP)]. Malofiejew M. Rocz Akad Med Im Juliana Marchlewskiego Bialymst Suppl; 1968 Feb; 23():1-65. PubMed ID: 4310706 [No Abstract] [Full Text] [Related]
11. CNS and ACTH-like peptides: neurochemical response and interaction with opiates. Gispen WH, Reith ME, Schotman P, Wiegant VM, Zwiers H, de Wied D. Adv Biochem Psychopharmacol; 1977 Feb; 17():61-80. PubMed ID: 200081 [No Abstract] [Full Text] [Related]
12. Neuropeptides and central catecholamine systems: interactions in neuroendocrine and central cardiovascular regulation. Fuxe K, Andersson K, Locatelli V, Mutt V, Lundberg J, Hökfelt T, Agnati LF, Eneroth P, Bolme P. Adv Biochem Psychopharmacol; 1980 Feb; 22():37-50. PubMed ID: 6156580 [No Abstract] [Full Text] [Related]
13. Influence of fibrinogen degradation products (FDP) on the central nervous system and on the effects of centrally acting drugs. Buczko W, Moniuszko-Jakoniuk J. Pharmacology; 1975 Feb; 13(3):252-9. PubMed ID: 1153509 [Abstract] [Full Text] [Related]